14-Alkoxy- and 14-Acyloxypyridomorphinans: μ Agonist/δ Antagonist Opioid Analgesics with Diminished Tolerance and Dependence Side Effects
- 27 September 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (19), 8350-8363
- https://doi.org/10.1021/jm300686p
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Coexpression of δ- and μ-opioid receptors in nociceptive sensory neuronsProceedings of the National Academy of Sciences of the United States of America, 2010
- Bi- or multifunctional opioid peptide drugsLife Sciences, 2010
- Synaptic Mechanism for Functional Synergism between δ- and μ-Opioid ReceptorsJournal of Neuroscience, 2010
- 14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studiesBioorganic & Medicinal Chemistry Letters, 2009
- 14β-O-Cinnamoylnaltrexone and Related Dihydrocodeinones are Mu Opioid Receptor Partial Agonists with Predominant Antagonist ActivityJournal of Medicinal Chemistry, 2009
- Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of opioid receptor affinityTetrahedron, 2008
- Opioid ligands with mixed μ/δ opioid receptor interactions: An emerging approach to novel analgesicsThe AAPS Journal, 2006
- Basal opioid receptor activity, neutral antagonists, and therapeutic opportunitiesLife Sciences, 2005
- Antisense oligodeoxynucleotide to δ opioid receptors attenuates morphine dependence in miceLife Sciences, 1997
- Estrogen and parathyroid hormone regulate insulin-like growth factor binding protein-4 in SaOS-2 cellsLife Sciences, 1997